Skip to main content
Top
Published in: Lung 5/2018

01-10-2018 | Letter to the Editor

Ventilator Weaning: How Far from the Final Quantum Leap?

Authors: Luca Salvatore De Santo, Antonio Esquinas

Published in: Lung | Issue 5/2018

Login to get access

Excerpt

Dear Editor, we read with great interest the paper by Palkar and co-workers [1]. These authors should be commended for their efforts in weaning research. Indeed, this article is part of a larger prospective observational study on the predictive value of serial diaphragm ultrasonography that has been contemporarily published elsewhere [2]. We dare to submit here an overall comment since these two papers received a single-institutional review board approval, analysed the same patients group within the same time frame, underwent a uniform ultrasonographic method and global clinical management, and, finally, speculated on the same outcome measure (extubation failure). In a small series of patients in a medical intensive care unit, this research group serially tracked diaphragm excursion and contraction velocity during weaning process and early after extubation. Further, they developed and evaluated the performance of a new parameter, the excursion-time index, which is a product of diaphragm excursion and inspiratory time. Study methodology is overall sound, but some issues might deserve further comments by the authors. Patients’ sample is poorly characterised, and hardly homogeneous. Indeed, reasons for initial mechanical ventilation are not detailed in the two subgroups and patients displayed different potentials for extubation failure (seven patients out of twenty received pre-emptive non-invasive ventilation early after weaning). Provokingly, a reader might argue that this limited subgroup might prove more clinically intriguing and best suited for extensive research. More, there are no hints on the reasons for reintubation. As expected, the results of these observations are largely confirmative of previous evidence: diaphragmatic ultrasound parameters, either conventional or innovative, are imperfect predictors of extubation outcomes. The clinical bottom line, simply and sobering, remains that, since weaning failure is multifactorial in nature, it is naïve to think that a single parameter might predict the fate of a complex interplay. As described in methods section, diaphragmatic ultrasound monitoring was not factored in the decision making for weaning and subsequent indication for non-invasive support or reintubation. Methodology or limitation? A dichotomy is clear; currently, management algorithms fail to safely wean from MV as many as 20–30% of patients, but research programs still focus on a single, increasingly sophisticated, “salami slice” with no real potential for clinical breakthrough. Long ago, a seminal editorial asked “Is weaning an art or a science?” [3]. Maybe, the answer is simply both, if we totally commit to a patient-tailored approach and stick with a thorough, holistic, innovative look. …
Metadata
Title
Ventilator Weaning: How Far from the Final Quantum Leap?
Authors
Luca Salvatore De Santo
Antonio Esquinas
Publication date
01-10-2018
Publisher
Springer US
Published in
Lung / Issue 5/2018
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-018-0148-0

Other articles of this Issue 5/2018

Lung 5/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.